Wave Life Sciences Ltd (NASDAQ: WVE) stock suffered a major decline of -12.8% on 3/18/24. The shares closed at $5.67. Moreover, trading volume in this decline was unusually high at 180% of normal. The stock has declined -16.4% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
WVE's future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Wave Life Sciences is currently unrated.
Rating Review
The stock is currently unrated.